Insulin resistance overview

Jump to navigation Jump to search

Insulin resistance Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Insulin Resistance from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Insulin resistance overview On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Insulin resistance overview

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Insulin resistance overview

CDC on Insulin resistance overview

Insulin resistance overview in the news

Blogs on Insulin resistance overview

Directions to Hospitals Treating Insulin resistance

Risk calculators and risk factors for Insulin resistance overview

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Insulin resistance is the condition in which normal amounts of insulin are inadequate to produce a normal insulin response from fat, muscle and liver cells. Insulin resistance in fat cells results in hydrolysis of stored triglycerides, which elevates free fatty acids in the blood plasma. Insulin resistance in muscle reduces glucose uptake whereas insulin resistance in liver reduces glucose storage, with both effects serving to elevate blood glucose. High plasma levels of insulin and glucose due to insulin resistance often lead to metabolic syndrome and type 2 diabetes.

Insulin resistance could be the earliest predictor of Diabetes Mellitus type 2. Obesity, especially fat accumulation on the abdominal and intra-abdominal visceral area, and insulin resistance are linked to series of complications such as cardiovascular disease or CVD and type 2 diabetes.

References

Template:WH Template:WS